Didactics-Primary HPV for Cervical Cancer Screening

Video Transcription

Video Summary

In the video, geneticologist Natasha Phunjareun discusses the primary HPV screening for cervical cancer. Phunjareun emphasizes the goal of cervical cancer screening, which is to prevent morbidity and mortality by identifying and destroying true cancer precursors, such as persistent HPV infections. She explains that transient HPV infections are not precursors to cervical cancer. Phunjareun discusses the potential harms of screening, including stigma, disrupted relationships, anxiety, time loss, expense of unnecessary investigations, pain, injury, and adverse pregnancy outcomes. She cites studies on HPV prevalence and cancer incidence, highlighting that HPV infections are most common among young women, while cancer incidences peak in women aged 45 to 55. Phunjareun compares the sensitivity and specificity of cytology and HPV testing, highlighting the higher sensitivity of HPV testing. She also discusses the use of triage methods, such as cytology and HPV genotyping, for positive HPV cases. Phunjareun mentions screening guidelines from different organizations, including the WHO, USPSTF, American Cancer Society, and ACOG. She concludes by emphasizing the importance of consistent adherence to screening guidelines and improving screening rates among under-screened women. No credits were mentioned in the video transcript.

Asset Subtitle

Natacha Phoolcharoen
May 2022

Keywords

geneticologist

HPV screening

cervical cancer

precancerous HPV infections

screening guidelines